These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

792 related items for PubMed ID: 23570719

  • 1. Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions.
    Wu L, Zou Y, Deng C, Cheng R, Meng F, Zhong Z.
    Biomaterials; 2013 Jul; 34(21):5262-72. PubMed ID: 23570719
    [Abstract] [Full Text] [Related]

  • 2. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
    Wei R, Cheng L, Zheng M, Cheng R, Meng F, Deng C, Zhong Z.
    Biomacromolecules; 2012 Aug 13; 13(8):2429-38. PubMed ID: 22746534
    [Abstract] [Full Text] [Related]

  • 3. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
    Zhong Y, Yang W, Sun H, Cheng R, Meng F, Deng C, Zhong Z.
    Biomacromolecules; 2013 Oct 14; 14(10):3723-30. PubMed ID: 23998942
    [Abstract] [Full Text] [Related]

  • 4. Reduction-sensitive reversibly crosslinked biodegradable micelles for triggered release of doxorubicin.
    Xu Y, Meng F, Cheng R, Zhong Z.
    Macromol Biosci; 2009 Dec 08; 9(12):1254-61. PubMed ID: 19904724
    [Abstract] [Full Text] [Related]

  • 5. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release.
    Chen W, Zhong P, Meng F, Cheng R, Deng C, Feijen J, Zhong Z.
    J Control Release; 2013 Aug 10; 169(3):171-9. PubMed ID: 23306022
    [Abstract] [Full Text] [Related]

  • 6. Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles.
    Cui C, Xue YN, Wu M, Zhang Y, Yu P, Liu L, Zhuo RX, Huang SW.
    Biomaterials; 2013 May 10; 34(15):3858-69. PubMed ID: 23452389
    [Abstract] [Full Text] [Related]

  • 7. Facile construction of dual-bioresponsive biodegradable micelles with superior extracellular stability and activated intracellular drug release.
    Chen W, Meng F, Cheng R, Deng C, Feijen J, Zhong Z.
    J Control Release; 2015 Jul 28; 210():125-33. PubMed ID: 25987525
    [Abstract] [Full Text] [Related]

  • 8. pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride.
    Du Y, Chen W, Zheng M, Meng F, Zhong Z.
    Biomaterials; 2012 Oct 28; 33(29):7291-9. PubMed ID: 22795540
    [Abstract] [Full Text] [Related]

  • 9. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
    Zhan F, Chen W, Wang Z, Lu W, Cheng R, Deng C, Meng F, Liu H, Zhong Z.
    Biomacromolecules; 2011 Oct 10; 12(10):3612-20. PubMed ID: 21905663
    [Abstract] [Full Text] [Related]

  • 10. Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma.
    Wu Y, Chen W, Meng F, Wang Z, Cheng R, Deng C, Liu H, Zhong Z.
    J Control Release; 2012 Dec 28; 164(3):338-45. PubMed ID: 22800578
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reduction and pH dual-bioresponsive crosslinked polymersomes for efficient intracellular delivery of proteins and potent induction of cancer cell apoptosis.
    Sun H, Meng F, Cheng R, Deng C, Zhong Z.
    Acta Biomater; 2014 May 28; 10(5):2159-68. PubMed ID: 24440420
    [Abstract] [Full Text] [Related]

  • 13. pH-Responsive chimaeric pepsomes based on asymmetric poly(ethylene glycol)-b-poly(l-leucine)-b-poly(l-glutamic acid) triblock copolymer for efficient loading and active intracellular delivery of doxorubicin hydrochloride.
    Chen P, Qiu M, Deng C, Meng F, Zhang J, Cheng R, Zhong Z.
    Biomacromolecules; 2015 Apr 13; 16(4):1322-30. PubMed ID: 25759951
    [Abstract] [Full Text] [Related]

  • 14. pH and reduction dual-sensitive copolymeric micelles for intracellular doxorubicin delivery.
    Chen J, Qiu X, Ouyang J, Kong J, Zhong W, Xing MM.
    Biomacromolecules; 2011 Oct 10; 12(10):3601-11. PubMed ID: 21853982
    [Abstract] [Full Text] [Related]

  • 15. pH and reduction dual-bioresponsive polymersomes for efficient intracellular protein delivery.
    Zhang J, Wu L, Meng F, Wang Z, Deng C, Liu H, Zhong Z.
    Langmuir; 2012 Jan 31; 28(4):2056-65. PubMed ID: 22188099
    [Abstract] [Full Text] [Related]

  • 16. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M, Qian J, Liu X, Liu T, Wang H.
    Mater Sci Eng C Mater Biol Appl; 2015 May 31; 50():341-7. PubMed ID: 25746279
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y, Zhang J, Cheng R, Deng C, Meng F, Xie F, Zhong Z.
    J Control Release; 2015 May 10; 205():144-54. PubMed ID: 25596560
    [Abstract] [Full Text] [Related]

  • 19. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release.
    Pan YJ, Chen YY, Wang DR, Wei C, Guo J, Lu DR, Chu CC, Wang CC.
    Biomaterials; 2012 Sep 10; 33(27):6570-9. PubMed ID: 22704845
    [Abstract] [Full Text] [Related]

  • 20. One-pot synthesis of crosslinked amphiphilic polycarbonates as stable but reduction-sensitive carriers for doxorubicin delivery.
    Yi X, Zhang Q, Dong H, Zhao D, Xu JQ, Zhuo R, Li F.
    Nanotechnology; 2015 Oct 02; 26(39):395602. PubMed ID: 26357961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.